Acuta Capital Partners’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Acuta Capital Partners’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-43,430	Closed	-$1.28M	–	61
2015 Q4	$1.28M	Sell	43,430 -67,442	-61%	-$2.04M	0.61%	38
2015 Q3	$3.5M	Buy	+110,872	New	+$5.3M	2.03%	13
2015 Q2	–	Sell	-35,000	Closed	-$3.74M	–	69
2015 Q1	$3.74M	Sell	35,000 -25,408	-42%	-$2.42M	3.15%	10
2014 Q4	$5.67M	Buy	+60,408	New	+$5.76M	3.83%	5

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acuta Capital Partners's PTX Position: Q1 2016 in Review

Acuta Capital Partners sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2016, closing a stake of 43,430 shares — an estimated $1.28M sold.

Acuta Capital Partners first reported a position in PTX in Q4 2014 and held it in 4 quarters. The position peaked at $5.67M in Q4 2014. 88 funds tracked by Wall St. Rank hold PTX as of Q1 2016.

Acuta Capital Partners reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2016 after selling out during the quarter.
Acuta Capital Partners sold 43,430 Pernix Therapeutics Holdings, Inc. shares in Q1 2016, an estimated $1.28M.
Acuta Capital Partners first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2014 and held it in 4 quarters.
Acuta Capital Partners's Pernix Therapeutics Holdings, Inc. position peaked at $5.67M in Q4 2014.
88 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2016.

Based on Acuta Capital Partners's 13F filing for Q1 2016, filed 13 May 2016.